DYN Live signals | Maximize Profits with Getagraph.com

BUY 31021 min ago

@ $28.36

Issued: 3 Apr 2024 @ 15:41

Return: -11.90%

Previous signal: Apr 3 - 12:52

Previous signal: Sell

Return: -0.51 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States...

Stats
Today's Volume	684 720
Average Volume	1.42M
Market Cap	2.03B
EPS	$0 ( 2024-03-07 )
Next earnings date	( $-0.800 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.32
ATR14	$0.0330 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Cox John	Sell	0	Common Stock
2023-07-11	Mcneill Jonathan	Buy	35 000	Stock option (right to buy)
2024-03-25	Cox John	Buy	679 853	Stock Option (Right to Buy)
2024-03-25	Cox John	Sell	0	Common Stock
2024-03-08	High Susanna Gatti	Sell	26 908	Common Stock

INSIDER POWER
-35.83
Last 100 transactions
Buy: 1 463 541 \| Sell: 3 129 182

Volume Correlation

Long: -0.16 (neutral)

Short: 0.73 (moderate)

Signal:(40.972) Neutral

Dynegy Inc. Correlation

10 Most Positive Correlations
TDI	0.868
TG	0.836
WBS-PF	0.835
ASB-PE	0.832
HPP-PC	0.827
LAZ	0.825
FPE	0.814
HRI	0.814
TPC	0.812
ASB-PF	0.812

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dynegy Inc. Correlation - Currency/Commodity

-0.78
( moderate negative )

-0.79
( moderate negative )

0.00
( neutral )

-0.82
( strong negative )

0.72
( moderate )

0.77
( moderate )

Dynegy Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-2.46M (0.00 %)
EPS:	$-3.95

Q4	2023
Revenue:	$3.79M
Gross Profit:	$3.22M (85.03 %)
EPS:	$-1.090

Q3	2023
Revenue:	$0
Gross Profit:	$-597 000 (0.00 %)
EPS:	$-0.990

Q2	2023
Revenue:	$0
Gross Profit:	$-674 000 (0.00 %)
EPS:	$-1.080

Financial Reports:

No articles found.

Dynegy Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..